Searched over 200M research papers
10 papers analyzed
These studies suggest that metoprolol can cause central nervous system complications, increased hospitalization for COPD exacerbation, adverse interactions with certain antidepressants, and a higher risk of bradycardia in CYP2D6 poor metabolizers.
20 papers analyzed
Metoprolol is a widely used beta-blocker prescribed for various cardiovascular conditions, including hypertension, angina pectoris, and heart failure. Despite its efficacy, metoprolol is associated with several side effects that can impact patient compliance and quality of life.
Metoprolol can significantly reduce heart rate and blood pressure, which is beneficial for treating hypertension and heart conditions. However, these effects can sometimes lead to adverse outcomes such as bradycardia (abnormally slow heart rate) and hypotension (low blood pressure) . Patients with CYP2D6 polymorphisms, particularly poor metabolizers, are at a higher risk of experiencing bradycardia due to increased drug levels in the bloodstream.
In patients with chronic obstructive pulmonary disease (COPD), metoprolol has been shown to increase the risk of exacerbations leading to hospitalization. A study found that patients treated with metoprolol had a higher incidence of COPD exacerbations compared to those on a placebo. This highlights the need for careful consideration when prescribing metoprolol to patients with respiratory conditions.
Metoprolol is known to cross the blood-brain barrier, leading to various CNS side effects. These include vivid dreams, sleep disturbances, hallucinations, and even psychosis . A study comparing metoprolol with atenolol found that metoprolol was associated with a higher incidence of sleep disturbances and restless nights. Elderly patients, in particular, may experience increased confusion, fatigue, and other neuropsychiatric symptoms.
Gastrointestinal issues such as nausea, vomiting, and diarrhea are common side effects of metoprolol. In a study involving hypertensive patients, gastrointestinal disturbances were among the most frequently reported side effects, leading to treatment withdrawal in some cases.
Other general side effects include dizziness, headache, and temporary fatigue. These symptoms are usually mild but can affect the patient's daily activities and overall well-being .
Metoprolol is metabolized by the CYP2D6 enzyme. Co-administration with CYP2D6 inhibitors like paroxetine or fluoxetine can lead to increased levels of metoprolol, exacerbating its side effects. This interaction can result in significant decreases in systolic blood pressure and heart rate, and in some cases, severe bradycardia and atrioventricular block.
While metoprolol is an effective treatment for various cardiovascular conditions, it is associated with a range of side effects that can impact patient safety and treatment adherence. These include cardiovascular issues like bradycardia and hypotension, CNS effects such as sleep disturbances and psychiatric symptoms, and gastrointestinal problems. Understanding these side effects and monitoring patients closely can help mitigate risks and improve therapeutic outcomes.
Most relevant research papers on this topic